Lacosamide Zentiva (Lacosamide)

Lacosamide works by enhancing the slow inactivation of voltage‑gated sodium channels in neuronal membranes. This action stabilizes hyperexcitable neurons, decreasing the likelihood of repetitive firing that can lead to seizures. By targeting the slow inactivation phase, it modulates excitability without markedly affecting normal nerve conduction.

The appropriate dose of Lacosamide Zentiva is determined by the prescribing clinician based on the patient’s clinical condition, response, and tolerability. Dosage adjustments may be needed for renal or hepatic impairment, and the prescriber will provide individualized dosing instructions.

Safety data for Lacosamide in pregnancy and lactation are limited. Healthcare providers should weigh the potential benefits against possible risks to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss treatment options with their physician before using Lacosamide.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials, then respond with pricing, availability, shipping details, and any necessary import documentation.

Lacosamide belongs to the sodium channel blocker class, offering a unique mechanism that enhances slow inactivation of sodium channels. Compared with other anticonvulsants such as carbamazepine or phenytoin, it may have a more favorable interaction profile and a lower risk of certain enzyme‑inducing effects, though individual response varies.

Lacosamide Zentiva tablets should be stored at ambient temperature, below 25 °C, in the original container to protect them from moisture and light. Keep the medication out of reach of children and avoid storing in humid or excessively hot environments.

Lacosamide Zentiva is taken orally, usually as a tablet, with or without food as directed by the prescriber. The tablets should be swallowed whole with water and not crushed or chewed unless specifically instructed by a healthcare professional.

Serious risks include cardiac arrhythmias such as PR‑interval prolongation, severe skin reactions like Stevens‑Johnson syndrome, and rare but critical psychiatric effects including suicidal thoughts. Patients should be monitored regularly for any signs of these conditions, and immediate medical attention is required if they occur.

Lacosamide Zentiva is contraindicated in patients with known hypersensitivity to Lacosamide or any of its excipients. Individuals with significant cardiac conduction abnormalities, uncontrolled severe hepatic or renal impairment, or those taking interacting medications that cannot be safely managed should avoid using this drug unless a specialist advises otherwise.